The nuclear expression of ARID1A has been negatively associated with tumor size, pathological grade, tumor recurrence, and survival in human HCC patients [48], while somatic mutations in ARID1A have been reported in HCC [49]. The gene discussed is ARID1A; the disease is hepatocellular carcinoma.